Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3727K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sierra, J. R. Articles by Giordano, S. Search for Related Content PubMed PubMed Citation Articles by Sierra, J. R. Articles by Giordano, S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Cancer Social Bookmarking                            What's this?

¹ Institute for Cancer Research and Treatment, University of Torino Medical School, 10060 Candiolo (Torino), Italy
² Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan

CORRESPONDENCE Silvia Giordano: silvia.giordano{at}unito.it

Increased evidence suggests that cancer-associated inflammation supports tumor growth and progression. We have previously shown that semaphorin 4D (Sema4D), a ligand produced by different cell types, is a proangiogenic molecule that acts by binding to its receptor, plexin B1, expressed on endothelial cells (Conrotto, P., D. Valdembri, S. Corso, G. Serini, L. Tamagnone, P.M. Comoglio, F. Bussolino, and S. Giordano. 2005. Blood. 105:4321–4329). The present work highlights the role of Sema4D produced by the tumor microenvironment on neoplastic angiogenesis. We show that in an environment lacking Sema4D, the ability of cancer cells to generate tumor masses and metastases is severely impaired. This condition can be explained by a defective vascularization inside the tumor. We demonstrate that tumor-associated macrophages (TAMs) are the main cells producing Sema4D within the tumor stroma and that their ability to produce Sema4D is critical for tumor angiogenesis and vessel maturation. This study helps to explain the protumoral role of inflammatory cells of the tumor stroma and leads to the identification of an angiogenic molecule that might be a novel therapeutic target.

P. Conrotto's present address is Dept. of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.

© 2008 Sierra et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A. (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081 [Abstract] [Full Text]  
• Capparuccia, L., Tamagnone, L. (2009). Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin. J. Cell Sci. 122: 1723-1736 [Abstract] [Full Text]  
• Ojalvo, L. S., King, W., Cox, D., Pollard, J. W. (2009). High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors. Am. J. Pathol. 174: 1048-1064 [Abstract] [Full Text]  
• Catalano, A., Lazzarini, R., Di Nuzzo, S., Orciari, S., Procopio, A. (2009). The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-{kappa}B to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells. Cancer Res. 69: 1485-1493 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS